BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17325072)

  • 1. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.
    Li W; Salanitri J; Tutton S; Dunkle EE; Schneider JR; Caprini JA; Pierchala LN; Jacobs PM; Edelman RR
    Radiology; 2007 Mar; 242(3):873-81. PubMed ID: 17325072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.
    Bashir MR; Mody R; Neville A; Javan R; Seaman D; Kim CY; Gupta RT; Jaffe TA
    J Magn Reson Imaging; 2014 Jul; 40(1):113-8. PubMed ID: 24130008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
    Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
    Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent.
    Huang SY; Kim CY; Miller MJ; Gupta RT; Lessne ML; Horvath JJ; Boll DT; Evans PD; Befera NT; Krishnan P; Chan JL; Merkle EM
    AJR Am J Roentgenol; 2013 Jul; 201(1):208-14. PubMed ID: 23789677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic lesions: improved image quality and detection with the periodically rotated overlapping parallel lines with enhanced reconstruction technique--evaluation of SPIO-enhanced T2-weighted MR images.
    Hirokawa Y; Isoda H; Maetani YS; Arizono S; Shimada K; Okada T; Shibata T; Togashi K
    Radiology; 2009 May; 251(2):388-97. PubMed ID: 19401572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
    Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular artifact mimicking thrombosis on MR imaging using ferumoxytol as a contrast agent in abdominal vascular assessment.
    Fananapazir G; Marin D; Suhocki PV; Kim CY; Bashir MR
    J Vasc Interv Radiol; 2014 Jun; 25(6):969-76. PubMed ID: 24630749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure.
    Sigovan M; Gasper W; Alley HF; Owens CD; Saloner D
    Radiology; 2012 Nov; 265(2):584-90. PubMed ID: 22875796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography.
    Stabi KL; Bendz LM
    Ann Pharmacother; 2011 Dec; 45(12):1571-5. PubMed ID: 22045905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
    Vymazal J; Spuentrup E; Cardenas-Molina G; Wiethoff AJ; Hartmann MG; Caravan P; Parsons EC
    Invest Radiol; 2009 Nov; 44(11):697-704. PubMed ID: 19809344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA).
    Enden T; Storås TH; Negård A; Haig Y; Sandvik L; Gjesdal KI; Sandset PM; Kløw NE
    J Magn Reson Imaging; 2010 Feb; 31(2):416-24. PubMed ID: 20099355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep vein thrombosis using noncontrast-enhanced MR venography with electrocardiographically gated three-dimensional half-Fourier FSE: preliminary experience.
    Ono A; Murase K; Taniguchi T; Shibutani O; Takata S; Kobashi Y; Miyazaki M
    Magn Reson Med; 2009 Apr; 61(4):907-17. PubMed ID: 19195017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic and lower extremity veins: contrast-enhanced three-dimensional MR venography with a dedicated vascular coil-initial experience.
    Ruehm SG; Wiesner W; Debatin JF
    Radiology; 2000 May; 215(2):421-7. PubMed ID: 10796919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
    Burns PN; Wilson SR
    Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent.
    Spuentrup E; Wiethoff AJ; Parsons EC; Spangenberg P; Stracke CP
    Eur J Radiol; 2010 Jun; 74(3):445-52. PubMed ID: 19394183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional black-blood T1-weighted turbo spin-echo techniques for the diagnosis of deep vein thrombosis in comparison with contrast-enhanced magnetic resonance imaging: a pilot study.
    Treitl KM; Treitl M; Kooijman-Kurfuerst H; Kammer NN; Coppenrath E; Suderland E; Czihal M; Hoffmann U; Reiser MF; Saam T
    Invest Radiol; 2015 Jun; 50(6):401-8. PubMed ID: 25783228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings.
    Gunn AJ; Seethamraju RT; Hedgire S; Elmi A; Daniels GH; Harisinghani MG
    AJR Am J Roentgenol; 2013 Jul; 201(1):117-21. PubMed ID: 23789664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
    Lin G; Ng KK; Chang CJ; Wang JJ; Ho KC; Yen TC; Wu TI; Wang CC; Chen YR; Huang YT; Ng SH; Jung SM; Chang TC; Lai CH
    Radiology; 2009 Mar; 250(3):784-92. PubMed ID: 19244045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
    Matuszewski L; Persigehl T; Wall A; Meier N; Bieker R; Kooijman H; Tombach B; Mesters R; Berdel WE; Heindel W; Bremer C
    Radiology; 2007 Jan; 242(1):217-24. PubMed ID: 17116730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.
    Nguyen KL; Park EA; Yoshida T; Hu P; Finn JP
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):106. PubMed ID: 29284494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.